Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 07, 2018

SELL
$13.3 - $17.49 $5,878 - $7,730
-442 Closed
0 $0
Q1 2018

May 10, 2018

SELL
$12.26 - $18.98 $3,678 - $5,694
-300 Reduced 40.43%
442 $7,000
Q4 2017

Jan 25, 2018

SELL
$13.68 - $23.17 $3,214 - $5,444
-235 Reduced 24.05%
742 $14,000
Q3 2017

Nov 01, 2017

BUY
$19.86 - $26.53 $19,403 - $25,919
977
977 $22,000

Others Institutions Holding KALA

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0

About Kala Pharmaceuticals, Inc.


  • Ticker KALA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,464,160
  • Market Cap $10M
  • Description
  • Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...
More about KALA
Track This Portfolio

Track First Personal Financial Services Portfolio

Follow First Personal Financial Services and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Personal Financial Services, based on Form 13F filings with the SEC.

News

Stay updated on First Personal Financial Services with notifications on news.